Marker Therapeutics Inc (MRKR)

[microcapbiotech]

I see 11 patients with 2 relapses. What will the market say.
MRKR hit a double, or MRKR hit a triple.
The problem is, for reasons I don't understand, unless MRKR hits home runs and grand slams, the market just shrugs it off, like no big deal.

No big deal, people are living in remission for 20/30/40/50 months now, nothing to see here?????????